Literature DB >> 13678977

Tuberculosis.

Thomas R Frieden1, Timothy R Sterling, Sonal S Munsiff, Catherine J Watt, Christopher Dye.   

Abstract

Among communicable diseases, tuberculosis is the second leading cause of death worldwide, killing nearly 2 million people each year. Most cases are in less-developed countries; over the past decade, tuberculosis incidence has increased in Africa, mainly as a result of the burden of HIV infection, and in the former Soviet Union, owing to socioeconomic change and decline of the health-care system. Definitive diagnosis of tuberculosis remains based on culture for Mycobacterium tuberculosis, but rapid diagnosis of infectious tuberculosis by simple sputum smear for acid-fast bacilli remains an important tool, and more rapid molecular techniques hold promise. Treatment with several drugs for 6 months or more can cure more than 95% of patients; direct observation of treatment, a component of the recommended five-element DOTS strategy, is judged to be the standard of care by most authorities, but currently only a third of cases worldwide are treated under this approach. Systematic monitoring of case detection and treatment outcomes is essential to effective service delivery. The proportion of patients diagnosed and treated effectively has increased greatly over the past decade but is still far short of global targets. Efforts to develop more effective tuberculosis vaccines are under way, but even if one is identified, more effective treatment systems are likely to be required for decades. Other modes of tuberculosis control, such as treatment of latent infection, have a potentially important role in some contexts. Until tuberculosis is controlled worldwide, it will continue to be a major killer in less-developed countries and a constant threat in most of the more-developed countries.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13678977     DOI: 10.1016/S0140-6736(03)14333-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  226 in total

1.  Targeting tuberculosis through a small focused library of 1,2,3-triazoles.

Authors:  Guillermo R Labadie; Agustina de la Iglesia; Héctor R Morbidoni
Journal:  Mol Divers       Date:  2011-06-02       Impact factor: 2.943

2.  Computed tomography imaging of acute neck inflammatory processes.

Authors:  Wessam Bou-Assaly; Jason McKellop; Suresh Mukherji
Journal:  World J Radiol       Date:  2010-03-28

3.  Zebrafishing for tuberculosis infection.

Authors:  Liwei Wang
Journal:  Protein Cell       Date:  2010-04       Impact factor: 14.870

4.  Phosphorylation of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA regulates mycolic acid biosynthesis.

Authors:  Romain Veyron-Churlet; Isabelle Zanella-Cléon; Martin Cohen-Gonsaud; Virginie Molle; Laurent Kremer
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

5.  Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school-based supervised asthma therapy.

Authors:  Lynn B Gerald; Leslie A McClure; Joan M Mangan; Kathy F Harrington; Linda Gibson; Sue Erwin; Jody Atchison; Roni Grad
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

6.  Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis (MDR- TB) Compared with Non-MDR-TB Infections in Peninsular Malaysia.

Authors:  Omar Salad Elmi; Habsah Hasan; Sarimah Abdullah; Mat Zuki Mat Jeab; Zilfalil Ba; Nyi Nyi Naing
Journal:  Malays J Med Sci       Date:  2016-06-30

7.  In vitro T-cell profile induced by BCG Moreau in healthy Brazilian volunteers.

Authors:  C Ponte; L Peres; S Marinho; J Lima; M Siqueira; T Pedro; P De Luca; C Cascabulho; L R Castello-Branco; P R Z Antas
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Application of optical imaging to study of extrapulmonary spread by tuberculosis.

Authors:  Ying Kong; Selvakumar Subbian; Suat L G Cirillo; Jeffrey D Cirillo
Journal:  Tuberculosis (Edinb)       Date:  2009-12       Impact factor: 3.131

9.  Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccine.

Authors:  Steven C Derrick; Teresa H Evering; Vasan K Sambandamurthy; Kripa V Jalapathy; Tsungda Hsu; Bing Chen; Mei Chen; Robert G Russell; Ana Paula Junqueira-Kipnis; Ian M Orme; Steven A Porcelli; William R Jacobs; Sheldon L Morris
Journal:  Immunology       Date:  2006-10-31       Impact factor: 7.397

Review 10.  Revised guidelines for the diagnosis and control of tuberculosis: impact on management in the elderly.

Authors:  Paul Van den Brande
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.